The Evidence Based Rheumatology Podcast Michael Putman

Mixing it up again this week to discuss an editorial by Miguel Hernan and a systematic review of target trials in rheumatology. It's kind of a fun free-form stream of consciousness. Hope you enjoy! Links: 

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888052/

https://pubmed.ncbi.nlm.nih.gov/32381560/

 

Quick episode today. I wanted to share an editorial that was recently published in Rheumatology, where I and co-authors (Shannon Tai and Natalie Anumolu) discuss lessons from recent trials in AAV and SLE. 

 

Link to editorial: https://pubmed.ncbi.nlm.nih.gov/35438142/ 

After some delay, I finally get around to discussing ORAL-Surveillance, a post-marketing safety study of tofacitinib for rheumatoid arthritis. It's an incredibly important trial that will likely affect how all of us practice for the foreseeable future. Link to paper: 

 

https://www.nejm.org/doi/full/10.1056/NEJMoa2109927

After a winter hiatus, the podcast is back! Today I wanted to dive into a 'hotbutton' issue - the question of whether (or not) COVID-19 vaccines "work" for patients with rheumatic diseases. My answer is an emphatic "yes," albeit with a few caveats. Here are the papers I discuss: 

 

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00034-0/fulltext

https://pubmed.ncbi.nlm.nih.gov/35441151/

Hello again! Snappy episode this week about the exciting LoVAS trial, which compared a reduced dose steroid taper for ANCA vasculitis. Be sure to drop by my website at ebrheum.com to subscribe to my newsletter! 

In this episode, I talk with Dr. Andy Abril, Chair at the Division of Rheumatology at the Mayo Clinic in Jacksonville Florida.  Dr. Abril is one of the lead authors for the 2021 ACR Guidelines on  Takayasu’s arteritis.


This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening!